Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

被引：0

作者：

Clifford J Bailey

Jorge L Gross

Delphine Hennicken

Nayyar Iqbal

Traci A Mansfield

James F List

机构：

[1] Aston University,Life and Health Sciences

[2] Universidade Federal do Rio Grande do Sul,Endocrine Division

[3] Bristol-Myers Squibb,Global Biometric Services

[4] Parc de l'Alliance,Global Clinical Research

[5] Bristol-Myers Squibb,undefined

来源：

BMC Medicine | / 11卷

关键词：

Dapagliflozin; metformin; SGLT2; sodium-glucose cotransporter 2; glycemic control; type 2 diabetes;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 114 条

[51]

Yoon K(undefined)undefined undefined undefined undefined-undefined

[52]

Hruba V(undefined)undefined undefined undefined undefined-undefined

[53]

Elze M(undefined)undefined undefined undefined undefined-undefined

[54]

Langkilde A(undefined)undefined undefined undefined undefined-undefined

[55]

Parikh S(undefined)undefined undefined undefined undefined-undefined

[56]

Nauck MA(undefined)undefined undefined undefined undefined-undefined

[57]

Del PS(undefined)undefined undefined undefined undefined-undefined

[58]

Meier JJ(undefined)undefined undefined undefined undefined-undefined

[59]

Duran-Garcia S(undefined)undefined undefined undefined undefined-undefined

[60]

Rohwedder K(undefined)undefined undefined undefined undefined-undefined